Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Order Sisters Of Mercy QueenslfiledCriticalOrder Sisters Of Mercy Queensl
Priority to NZ335545ApriorityCriticalpatent/NZ335545A/en
Priority claimed from PCT/NZ1997/000134external-prioritypatent/WO1998015579A1/en
Publication of NZ335545ApublicationCriticalpatent/NZ335545A/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Abstract
A monoclonal antibody or binding fragments thereof which specifically bind to dendritic cells activation antigen CMRF-56. Disclosed is a hybridoma cell line CMRF-56 which secretes mAb CMRF-56. The secreted mAb CMRF-56 binds specifically to an epitope on activated human dendritic cell but does not bind to activation antigens CMRF-44 and CD83. The process provides a method for identifying and purifying dendritic cells from blood using such antibodies.
NZ335545A1996-10-091997-10-09Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56
NZ335545A
(en)
Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody